SAGITTARIUS LIFE SCIENCE CORP |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 41.9 TWD | +2.07% |
|
-4.45% | -19.73% |
| Sales 2022 | 529M 16.28M 22.21M | Sales 2023 | 440M 13.55M 18.49M | Capitalization | 1.7B 52.27M 71.33M |
|---|---|---|---|---|---|
| Net income 2022 | -74M -2.28M -3.11M | Net income 2023 | -55M -1.69M -2.31M | EV / Sales 2022 | 2.02 x |
| Net cash position 2022 | 258M 7.95M 10.85M | Net cash position 2023 | 202M 6.22M 8.48M | EV / Sales 2023 | 3.4 x |
| P/E ratio 2022 |
-17.9
x | P/E ratio 2023 |
-30.9
x | Employees | 112 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 67.7% |
More Fundamentals
* Assessed data
More news
| 1 day | +2.07% | ||
| 1 week | -4.45% | ||
| Current month | -1.18% | ||
| 1 month | -1.18% | ||
| 3 months | -6.89% | ||
| 6 months | -9.50% | ||
| Current year | -19.73% |
1 week
41.05
42.80
1 month
40.0545.00
Current year
40.0552.90
1 year
40.0560.90
3 years
20.6579.20
5 years
20.6579.20
10 years
20.65333.76
| Managers | Title | Age | Since |
|---|---|---|---|
Le Wei Chen
CEO | Chief Executive Officer | - | 04-04-28 |
Chun Heng Chen
DFI | Director of Finance/CFO | - | 19-11-14 |
Pao Hui Huang
BRD | Director/Board Member | - | 15-06-16 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Lien Chun Chiu
BRD | Director/Board Member | - | 03-06-29 |
Le Wei Chen
CEO | Chief Executive Officer | - | 04-04-28 |
Pao Hui Huang
BRD | Director/Board Member | - | 15-06-16 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-29 | 41.9 | +2.07% | 200,834 |
| 24-04-26 | 41.05 | -1.32% | 118,511 |
| 24-04-25 | 41.6 | -0.95% | 83,692 |
| 24-04-24 | 42 | -0.59% | 98,428 |
| 24-04-23 | 42.25 | -3.65% | 194,069 |
End-of-day quote Taipei Exchange, April 28, 2024
More quotes
Sagittarius Life Science Corp. is a Taiwan-based company principally engaged in the research, development, production and sales of health products. The Company's main products include various types of nutrition and health formulations, natural and organic food, beverages, probiotic fermentation products, beauty care ingredients, Chinese herbal medicines, plant new medicines and health supplies. The Company also provides related technical services for the research and development of Chinese and western pharmaceutical products. The Company distributes its products in domestic market and to overseas markets, such as the rest areas of Asia and the Americas.
Sector
Food Processing
| 1st Jan change | Capi. | |
|---|---|---|
| -19.73% | 40.96M | |
| +11.32% | 7.78B | |
| +1.64% | 7.38B | |
| +10.50% | 6.52B | |
| -6.69% | 3.67B | |
| -13.51% | 3.44B | |
| -10.10% | 1.17B | |
| +8.34% | 934M | |
| -41.81% | 879M | |
| -19.81% | 836M |
- Stock Market
- Equities
- 3205 Stock
